Target intelligence / Profile preview

Enteroendocrine cell chemoreceptor (EEC chemoreceptor)

Target
EEC chemoreceptor
Molecular classification
G protein-coupled receptor, Ion channel, Transporter, Receptor
01

Overview

Enteroendocrine cell chemoreceptors and sensory elements represent a diverse group of specialized proteins located on the luminal surface of the gastrointestinal epithelium. These elements, which include various G protein-coupled receptors (GPCRs) and ion channels, act as the primary interface for sensing dietary nutrients, microbial metabolites, and toxins within the gut lumen (Symonds et al., 2015, PubMed: 25831021). Upon activation, these sensors trigger the release of signaling molecules such as GLP-1, PYY, and serotonin, which regulate appetite, glucose homeostasis, and intestinal motility (Gribble & Reimann, 2016, PubMed: 27431365). While many specific receptors like TAS1R (sweet) and FFAR (fatty acids) are well-characterized, the term often encompasses a broader, sometimes ill-defined network of sensory machinery involved in the gut-brain axis. Dysregulation of these sensory pathways is linked to metabolic disorders like obesity and type 2 diabetes, as well as functional gastrointestinal disorders (Adriaenssens et al., 2018, PubMed: 30071161). Therapeutic strategies often aim to mimic or enhance these natural sensing mechanisms to treat metabolic and inflammatory conditions.

Other names
Gut chemosensorsGastrointestinal sensory receptorsEnteric nutrient sensorsEpithelial sensory elementsLuminal chemoreceptors
02

Mechanism of action

Activation of G protein-coupled receptors or ion channels on the apical surface of enteroendocrine cells to trigger the release of gut hormones (e.g., GLP-1, PYY, CCK) or neurotransmitters that modulate local motility and systemic metabolism.

03

Biological functions

Signal transductionHormone secretionNutrient sensingMetabolic regulationAppetite controlGut-brain axis signaling
04

Disease associations

ObesityType 2 diabetesIrritable bowel syndromeInflammatory bowel diseaseFunctional dyspepsia
05

Safety considerations

Gastrointestinal distress (nausea, vomiting, diarrhea)Off-target activation of similar receptors in other tissuesPotential for tachyphylaxis or receptor desensitizationRisk of pancreatitis with chronic overstimulation of certain pathways
06

Interacting drugs

4 more in the full profile.

07

Biomarkers

Glucagon-like peptide 1 (GLP-1) levelsPeptide YY (PYY) levelsCholecystokinin (CCK) levelsChromogranin A

Beyond the preview

Go deeper on Enteroendocrine cell chemoreceptor (EEC chemoreceptor).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enteroendocrine cell chemoreceptor (EEC chemoreceptor).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call